HUP0103419A3 - The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives - Google Patents

The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives

Info

Publication number
HUP0103419A3
HUP0103419A3 HU0103419A HUP0103419A HUP0103419A3 HU P0103419 A3 HUP0103419 A3 HU P0103419A3 HU 0103419 A HU0103419 A HU 0103419A HU P0103419 A HUP0103419 A HU P0103419A HU P0103419 A3 HUP0103419 A3 HU P0103419A3
Authority
HU
Hungary
Prior art keywords
cell line
related compounds
neurotrophic factor
derived neurotrophic
glial cell
Prior art date
Application number
HU0103419A
Other languages
Hungarian (hu)
Original Assignee
Saarma Mart
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI981793A external-priority patent/FI981793A0/en
Priority claimed from FI990415A external-priority patent/FI990415A0/en
Application filed by Saarma Mart filed Critical Saarma Mart
Publication of HUP0103419A2 publication Critical patent/HUP0103419A2/en
Publication of HUP0103419A3 publication Critical patent/HUP0103419A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Psychology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
HU0103419A 1998-08-21 1999-08-20 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives HUP0103419A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI981793A FI981793A0 (en) 1998-08-21 1998-08-21 Inhibition of sperm differentiation by GDNF
FI990415A FI990415A0 (en) 1999-02-26 1999-02-26 Use of Compounds Related to Glial Cell Line Neurotrophic Factor Family for the Control of Spermatogenesis and Preparation of Male Contraceptives
PCT/FI1999/000687 WO2000010594A1 (en) 1998-08-21 1999-08-20 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives

Publications (2)

Publication Number Publication Date
HUP0103419A2 HUP0103419A2 (en) 2002-01-28
HUP0103419A3 true HUP0103419A3 (en) 2004-06-28

Family

ID=26160633

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103419A HUP0103419A3 (en) 1998-08-21 1999-08-20 The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives

Country Status (14)

Country Link
EP (1) EP1105151A1 (en)
JP (1) JP2002523374A (en)
KR (1) KR20010088793A (en)
CN (1) CN1323218A (en)
AU (1) AU763678B2 (en)
CA (1) CA2338644A1 (en)
EE (1) EE200100103A (en)
HU (1) HUP0103419A3 (en)
IL (1) IL141037A0 (en)
NO (1) NO20010859L (en)
NZ (1) NZ509592A (en)
PL (1) PL346298A1 (en)
SK (1) SK2472001A3 (en)
WO (1) WO2000010594A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL198599B1 (en) * 1998-07-06 2008-07-31 Nsgene As Neublastin neurotrophic factor polypeptides, nucleic acids encoding neublastin polypeptides, and antibodies that bind specifically to neublastin polypeptides as well as methods of making and methods of using the same
FI20000403A0 (en) * 2000-02-22 2000-02-22 Hannu Sariola Use of GDNF family-related compounds for the preparation of testicular cancer treatment products
JPWO2006028278A1 (en) * 2004-09-09 2008-05-08 国立大学法人京都大学 Method for in vitro proliferation of male germline stem cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428977B1 (en) * 1995-12-20 2002-08-06 Curis, Inc. Signalin family of TGFβ signal transduction proteins, and uses related thereto
WO1997033911A1 (en) * 1996-03-14 1997-09-18 Washington University Persephin and related growth factors

Also Published As

Publication number Publication date
KR20010088793A (en) 2001-09-28
HUP0103419A2 (en) 2002-01-28
JP2002523374A (en) 2002-07-30
SK2472001A3 (en) 2001-09-11
AU5375299A (en) 2000-03-14
NZ509592A (en) 2003-01-31
WO2000010594A1 (en) 2000-03-02
EE200100103A (en) 2002-06-17
IL141037A0 (en) 2002-02-10
AU763678B2 (en) 2003-07-31
EP1105151A1 (en) 2001-06-13
PL346298A1 (en) 2002-01-28
NO20010859L (en) 2001-04-19
CN1323218A (en) 2001-11-21
CA2338644A1 (en) 2000-03-02
NO20010859D0 (en) 2001-02-20

Similar Documents

Publication Publication Date Title
HUP0102470A3 (en) 1,3-azole derivatives as retinoid-associated receptor regulators and their use
IL144147A0 (en) Regulators of the pct or smoothened pathway, compositions and uses related thereto
GB2335190B (en) 1-Alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
HUP9904631A3 (en) Fine-grained caoutchouc-powders, procedure for making them and the use thereof
AU6389299A (en) Inorganic oxides with mesoporosity or combined meso-and microporosity and process for the preparation thereof
PL332934A1 (en) The use of nano-dispersion for final cosmetic preparations
IL106300A0 (en) Flavor-enhancing composition containing colloidal silica,processes for the preparation and use thereof
PL332935A1 (en) The use of nano-dispersion for final cosmetic preparations
GB9810233D0 (en) Dispersion of pigments
AU1906295A (en) Silica-based sols, preparation and use of the sols
HUP0103419A3 (en) The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives
EP0845712A4 (en) Pigment composition for liquid toner, method of manufacturing the same and liquid toner manufacturing method
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
AU5318300A (en) Substituted 5-oxo-5,6,7,8-tetrahydro-4h-1-benzopyrans and benzothiopyrans and the use thereof as potentiators of ampa
HUP0100542A3 (en) Progestogen and antiprogestogen containing kit, process for its preparation and use of the compounds for the preparation of contraseptives
HUP9801646A3 (en) Process for the preparation of 2-chlor-benzimidazole derivatives and 1,3-dihidrobenzimidazol(thi)ones and preparation of the latters
IL119744A0 (en) Use of 8,9-dehydroestrone
AU6179498A (en) Controlled ferroresonant transformer
AU3253797A (en) Lifting tower and use of the lifting tower
AU4215699A (en) Stabilization of silica dispersions
AU2001295557A1 (en) Use of myxoxanthophyll and/or echinenone for the prophylactic and/or therapeutictreatment of undesirable physical conditions conditioned or favoured by oxidati ve processes
HU9500776D0 (en) Polyolefin based pigmented composition and procedure for making of shaped bodies starting from the composition
TW441730U (en) Structure of gas distribution valve
AU5197199A (en) Processes for the preparation of aromatic sulfenyl chlorides and so forth